|
NUVL | Nuvalent, Inc. |
|
|
NUVL | Nuvalent, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.46 |
| Leverage | 11.68% |
| Market Cap | $ 7.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -448.8m |
| Margin | 4315.50% |
None